Applied Stemcell

Applied Stemcell company information, Employees & Contact Information

Explore related pages

Related company profiles:

Advancing Gene and Cell Product Development Through iPSC and Genome Editing Technologies Applied StemCell strives to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry to assist in the development of breakthrough therapeutic approaches to cure intractable diseases. ASC is a trailblazing CRO/CDMO committed to building a complete iPSC-Gene Editing platform for the production of iPSC-derived products for gene and cell therapy research and development. With the integration of our unique iPSC approach and IP-based site-specific large cargo insertion technology, TARGATT™, we (1) develop immune-compatible master iPS cell lines and (2) deliver large DNA fragments to pluripotent cells that have proven differentiation capabilities. We stand at the forefront of the iPSC-based therapy revolution delivering research- and GMP-grade iPSC solutions along with various downstream assay services. Current Offerings: • iPSC Cell Line Models: iPSC generation, CRISPR & TARGATT™ genome editing, differentiation • Cell Gene Product CDMO: TARGATT™ iPSC Platform for allogeneic cell therapy products/GMP iPSC reprogramming, cell banking, gene editing, and differentiation • Bioproduction: TARGATT™ CHO cell system for antibody screening and bioproduction/TARGATT™ HEK293 cell system for library/antibody screening • Animal Models: Custom and off-the-shelf CRISPR & TARGATT™ mouse models For patent licensing, business development, and investment inquiries, please contact us at info@appliedstemcell.com.
Looking for a particular Applied Stemcell employee's phone or email?

Applied Stemcell Questions

News

Applied StemCell Announces Drug Master File Submission to the US FDA for their GMP-Grade iPSC Cell Line - Business Wire

Applied StemCell Announces Drug Master File Submission to the US FDA for their GMP-Grade iPSC Cell Line Business Wire

Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer - GlobeNewswire

Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer GlobeNewswire

New Frontiers in Gene-Editing and Stem Cell Innovation – Interview with Dr. Chen-Tsai of Applied StemCell - BioInformant

New Frontiers in Gene-Editing and Stem Cell Innovation – Interview with Dr. Chen-Tsai of Applied StemCell BioInformant

Applied StemCell Launches hiEX™ Research iPSC Exosomes to Power Next-Generation Regenerative Medicine Research - BioSpace

Applied StemCell Launches hiEX™ Research iPSC Exosomes to Power Next-Generation Regenerative Medicine Research BioSpace

Editorial: Advances in translational and applied stem cell biology - Frontiers

Editorial: Advances in translational and applied stem cell biology Frontiers

Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell's Gene Editing Platform and Oncology Product Portfolio - PR Newswire

Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell's Gene Editing Platform and Oncology Product Portfolio PR Newswire

QHP Capital Acquires Applied StemCell - Business Wire

QHP Capital Acquires Applied StemCell Business Wire

QHP buys Applied StemCell, adding cell and gene therapy specialist to pharma service portfolio - Fierce Biotech

QHP buys Applied StemCell, adding cell and gene therapy specialist to pharma service portfolio Fierce Biotech

Applied StemCell Licenses Its TARGATT™ CHO Cell Technology for Biotherapeutics Development - BioInformant

Applied StemCell Licenses Its TARGATT™ CHO Cell Technology for Biotherapeutics Development BioInformant

Advanced Gene Editing in Mouse Models for Biopharmaceutical Development - BioProcess International

Advanced Gene Editing in Mouse Models for Biopharmaceutical Development BioProcess International

CEO of Applied StemCell (ASC), Dr. Ruby Chen-Tsai, on ASC's Massive Plans for Expansion - BioInformant

CEO of Applied StemCell (ASC), Dr. Ruby Chen-Tsai, on ASC's Massive Plans for Expansion BioInformant

Applied StemCell Announces the Expansion of its cGMP Manufacturing Facility to Support Cell and Gene Therapy - BioInformant

Applied StemCell Announces the Expansion of its cGMP Manufacturing Facility to Support Cell and Gene Therapy BioInformant

Top Applied Stemcell Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant